NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
088 Region Stockholm

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 1742 7.0% 338 1.4% 128 0.5% 2 0.0% 10 0.0% 59 0.2% 22554 90.8% 24833 100.0%
ASCUS 1278 35.3% 601 16.6% 314 8.7% 14 0.4% 8 0.2% 59 1.6% 1342 37.1% 3616 100.0%
LSIL 738 30.2% 685 28.1% 358 14.7% 4 0.2% . . 20 0.8% 635 26.0% 2440 100.0%
Atypical glandular cells/AGC 102 38.3% 40 15.0% 54 20.3% 11 4.1% 5 1.9% 4 1.5% 50 18.8% 266 100.0%
Unclear atypia 10 25.6% 3 7.7% 1 2.6% . . 1 2.6% 1 2.6% 23 59.0% 39 100.0%
ASC-H 110 22.5% 74 15.1% 207 42.3% 5 1.0% 7 1.4% 5 1.0% 81 16.6% 489 100.0%
HSIL 82 11.0% 77 10.3% 407 54.5% 6 0.8% 9 1.2% 6 0.8% 160 21.4% 747 100.0%
Suspected Adenocarcinom 4 7.7% 1 1.9% 6 11.5% 9 17.3% 12 23.1% . . 20 38.5% 52 100.0%
Adenocarcinoma 1 25.0% . . . . . . 1 25.0% . . 2 50.0% 4 100.0%
Malignant tumor with unclear origin 1 9.1% . . 1 9.1% . . 4 36.4% . . 5 45.5% 11 100.0%
Squamous cell cancer . . 1 5.6% 3 16.7% . . 8 44.4% . . 6 33.3% 18 100.0%
Totalt 4068 12.5% 1820 5.6% 1479 4.5% 51 0.2% 65 0.2% 154 0.5% 24878 76.5% 32515 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M80001, M80703, M81403, M82003, M83803, M85603